Positron emission tomography (PET) with fluorine-18 fluorodeoxyglucose (FDG) is a
radiotracer imaging method that is used in the care of patients with cancer. We conducted a …

The basis of tumour imaging with PET is a specific uptake mechanism of positron emitting
radiopharmaceuticals. Among the potential tracers for breast cancer (fluorodeoxyglucose …

Objectives The early detection of suspiciously recurrent breast cancer is of significant
importance. The aim of the present meta-analysis was to evaluate the overall diagnostic …

RATIONALE AND OBJECTIVES: The authors performed this study to determine the
feasibility of using quantitative 2-[fluorine-18] fluoro-2-deoxy-d-glucose (FDG) positron …

Changes in tumor metabolic activity have been shown to be an early indicator of treatment
effectiveness for breast cancer, mainly in the neoadjuvant setting. The histopathologic …

We aimed to compare the value of combined positron emission tomography (PET)/CT, PET+
CT (viewed side by side), CT alone and PET alone concerning the rTNM stage and …

Background: The aim of this study was to evaluate the effect on the number of performed
biopsies and costs associated with implementing positron emission tomography (PET) and …

Objetive To assess the safety and efficacy of FDG-PET in breast cancer in the diagnostic of
primary tumours, lymph node staging, the detection of recurrent disease/metastases, and the …

Purpose This retrospective study aimed (1) to compare the diagnostic accuracy of whole-
body FDG PET/CT for initial breast cancer staging with the accuracy of a conventional …

Cases of recurrence of breast cancer can pose considerable diagnostic and therapeutic
challenges for the oncologic team. The prognosis and management decisions are based on …